Reduced Myocardial Perfusion Reserve in Type 2 Diabetes Is Caused by Increased Perfusion at Rest and Decreased Maximal Perfusion During Stress.
Adenosine
/ pharmacology
Adult
Aged
Case-Control Studies
Coronary Circulation
/ drug effects
Cross-Sectional Studies
Diabetes Mellitus, Type 2
/ diagnostic imaging
Echocardiography
Female
Heart
/ diagnostic imaging
Humans
Magnetic Resonance Angiography
Male
Middle Aged
Myocardial Perfusion Imaging
Rest
/ physiology
Stress, Physiological
/ drug effects
Vasodilator Agents
/ pharmacology
Journal
Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
30
10
2019
accepted:
07
02
2020
pubmed:
21
3
2020
medline:
27
2
2021
entrez:
21
3
2020
Statut:
ppublish
Résumé
To examine differences in myocardial blood flow (MBF) at rest and during stress between patients with type 2 diabetes and control subjects, and to identify potential predictors of changes in MBF at rest and during stress. A cross-sectional study was conducted of 193 patients with type 2 diabetes and 20 age- and sex-matched control subjects. Cardiovascular magnetic resonance was used to evaluate left ventricular structure and function and MBF at rest and during adenosine-induced stress. MBF was derived as the mean of the flow within all segments of a midventricular slice. Patients with type 2 diabetes had higher global MBF at rest (0.81 ± 0.19 mL/min/g) and lower global MBF during stress (2.4 ± 0.9 mL/min/g) than control subjects (0.61 ± 0.11 at rest, 3.2 ± 0.8 mL/min/g under stress; both Patients with type 2 diabetes have higher global MBF at rest and lower maximal MBF during vasodilator-induced stress than control subjects. Reduced MBF during stress is associated with diabetes complications (albuminuria and retinopathy) and is inversely correlated with diffuse myocardial fibrosis.
Identifiants
pubmed: 32193248
pii: dc19-2172
doi: 10.2337/dc19-2172
doi:
Substances chimiques
Vasodilator Agents
0
Adenosine
K72T3FS567
Banques de données
ClinicalTrials.gov
['NCT02684331']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1285-1292Informations de copyright
© 2020 by the American Diabetes Association.